Trial intelligence / Profile preview

Bromocriptine QR in Type 1 Diabetes

NCT02544321Phase 2Completed

Sponsor
University of Colorado Denver
Start
Sep 2015
Primary completion
Jun 2019
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of bromocriptine in type 1 diabetes mellitus (T1D), sponsored by University of Colorado Denver. Started Sep 2015; status: completed.

02

Drugs

bromocriptine
03

Conditions

type 1 diabetes mellitus (T1D)

Beyond the preview

Go deeper on NCT02544321.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02544321.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call